Agilent AdvanceBio Peptide Mapping columns are designed to provide high-resolution peptide maps for protein identification and determination of post translation modifications. These columns provide the ability for you to quickly resolve and identify amino acid substitutions/modifications in a protein primary sequence. These advanced biocolumns are superficially porous and have a 120 Å pore size, which is optimum for the analysis of the peptides produced by enzymatic digest of proteins. The 2.7 µm particle size enables UHPLC performance on HPLC systems, which delivers high resolution separations 2–3 times faster than with fully porous HPLC columns. Each batch of the AdvanceBio Peptide Mapping media is tested with a peptide mix to ensure suitability and reproducibility, and to provide greater confidence in the analytical data generated. Use Agilent’s 10-Peptide Quality Control Standard, the same standard Agilent uses to QC its columns, to evaluate your column’s performance over its lifetime. It can be used for HPLC or LC/MS. Approximately 20 injections per vial. Order part number 5190-0583. AdvanceBio Peptide Mapping columns are the first members of Agilent’s growing state-of-the-art family of biocolumns. They are designed to deliver consistent, exceptional performance for the separation and characterization of peptides and proteins.
AdvanceBio RP-mAb columns are designed to optimize the performance of intact and reduced mAb analysis when analyzing monoclonal antibodies for biopharma discovery, development, and QA/QC applications. Analysis of intact and reduced monoclonal antibodies are critical measurements for characterizing therapeutic proteins and understanding their efficacy and stability. Poor chromatographic separations can result in rework and even compromise the accuracy of the characterization. Based on Poroshell technology with unique engineering for pore size and bonded phases, AdvanceBio RP-mAb columns deliver higher resolution and faster run times to provide accurate, reproducible results. Available in a range of chemistries – SB-C8, C4, and diphenyl. View our full range of bioHPLC columns for your area of interest, get resources, and take advantage of special offers . Features: • Improved accuracy: Superficially porous particles (3.5 µm) with wide pores (450Å) increase mAb resolution while maintaining compatibility with all LC instruments • Speed: Shorter analysis times compared to columns packed with fully porous particles of the same size • Lower costs: The robust Poroshell packed bed and 2 µ inlet frit extend column lifetime by helping prevent inlet blockage
AdvanceBio RP-mAb columns are designed to optimize the performance of intact and reduced mAb analysis when analyzing monoclonal antibodies for biopharma discovery, development, and QA/QC applications. Analysis of intact and reduced monoclonal antibodies are critical measurements for characterizing therapeutic proteins and understanding their efficacy and stability. Poor chromatographic separations can result in rework and even compromise the accuracy of the characterization. Based on Poroshell technology with unique engineering for pore size and bonded phases, AdvanceBio RP-mAb columns deliver higher resolution and faster run times to provide accurate, reproducible results. Available in a range of chemistries – SB-C8, C4, and diphenyl. View our full range of bioHPLC columns for your area of interest, get resources, and take advantage of special offers . Features: • Improved accuracy: Superficially porous particles (3.5 µm) with wide pores (450Å) increase mAb resolution while maintaining compatibility with all LC instruments • Speed: Shorter analysis times compared to columns packed with fully porous particles of the same size • Lower costs: The robust Poroshell packed bed and 2 µ inlet frit extend column lifetime by helping prevent inlet blockage
AdvanceBio RP-mAb columns are designed to optimize the performance of intact and reduced mAb analysis when analyzing monoclonal antibodies for biopharma discovery, development, and QA/QC applications. Analysis of intact and reduced monoclonal antibodies are critical measurements for characterizing therapeutic proteins and understanding their efficacy and stability. Poor chromatographic separations can result in rework and even compromise the accuracy of the characterization. Based on Poroshell technology with unique engineering for pore size and bonded phases, AdvanceBio RP-mAb columns deliver higher resolution and faster run times to provide accurate, reproducible results. Available in a range of chemistries – SB-C8, C4, and diphenyl. View our full range of bioHPLC columns for your area of interest, get resources, and take advantage of special offers . Features: • Improved accuracy: Superficially porous particles (3.5 µm) with wide pores (450Å) increase mAb resolution while maintaining compatibility with all LC instruments • Speed: Shorter analysis times compared to columns packed with fully porous particles of the same size • Lower costs: The robust Poroshell packed bed and 2 µ inlet frit extend column lifetime by helping prevent inlet blockage
HC-C18, 4.6 x 250 mm, 5 u, 2.5 ml solvent, 4.2 ml tube
Please fill out your contact data and your information request, we will contact you as soon as possible with all requested information.
Please fill out your contact data and your information request, we will contact you as soon as possible with all requested information.
